CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
CYTH
Delisted
CYTH was delisted on the 25th of March, 2025.
23 hedge funds and large institutions have $2.1M invested in Cyclo Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
Holders
23
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$613K | |
| 2 | +$140K | |
| 3 | +$93.3K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$65.7K |
| 5 |
BlackRock
New York
|
+$61.3K |
Top Sellers
| 1 | -$15K | |
| 2 | -$2.81K | |
| 3 | -$1.14K | |
| 4 |
JP Morgan Chase
New York
|
-$283 |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$125 |